|
Volumn 4, Issue 3, 2007, Pages 149-152
|
Effects of telmisartan on hypertensive patients with dyslipidemia and insulin resistance
|
Author keywords
Hypertension; Insulin resistance; Lipid metabolism; Telmisartan
|
Indexed keywords
ENALAPRIL;
GLUCOSE;
HIGH DENSITY LIPOPROTEIN CHOLESTEROL;
INSULIN;
LIPID;
TELMISARTAN;
TRIACYLGLYCEROL;
ADULT;
ARTICLE;
BIOCHEMISTRY;
BLOOD PRESSURE REGULATION;
CHOLESTEROL BLOOD LEVEL;
CLINICAL ASSESSMENT;
CLINICAL TRIAL;
COMORBIDITY;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG EFFECT;
DYSLIPIDEMIA;
FEMALE;
GLUCOSE BLOOD LEVEL;
HEART RATE;
HUMAN;
HYPERTENSION;
INSULIN BLOOD LEVEL;
INSULIN RESISTANCE;
INSULIN SENSITIVITY;
LIPID BLOOD LEVEL;
MAJOR CLINICAL STUDY;
MALE;
POSTPRANDIAL STATE;
RANDOMIZED CONTROLLED TRIAL;
STATISTICAL SIGNIFICANCE;
TREATMENT DURATION;
TRIACYLGLYCEROL BLOOD LEVEL;
|
EID: 35948937604
PISSN: 16715411
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (4)
|
References (8)
|